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ABSTRACT
A recent systematic review identified few papers on the 
economic evaluation of systems for emergency transport 
of acutely ill or injured patients. In addition, we found no 
articles dealing with the methodological challenges posed by 
such studies in low- income or middle- income countries. We 
therefore carried out an analysis of issues that are of particular 
salience to this important topic. This is an intellectual study in 
which we develop models, identify their limitations, suggest 
potential extensions to the models and discuss priorities for 
empirical studies to populate models. First, we develop a 
general model to calculate changes in survival contingent on 
the reduced time to treatment that an emergency transport 
system is designed to achieve. Second, we develop a model 
to estimate transfer times over an area that will be served 
by a proposed transfer system. Third, we discuss difficulties 
in obtaining parameters with which to populate the models. 
Fourth, we discuss costs, both direct and indirect, of an 
emergency transfer service. Fifth, we discuss the issue that 
outcomes other than survival should be considered and that the 
effects of a service are a weighted sum over all the conditions 
and severities for which the service caters. Lastly, based on 
the above work, we identify priorities for research. To our 
knowledge, this is the first study to identify and frame issues in 
the health economics of acute transfer systems and to develop 
models to calculate survival rates from basic parameters, such 
as time delay/survival relationships, that vary by intervention 
type and context.
INTRODUCTION
Decisions about implementing new inter-
ventions need to reflect resource constraints; 
evidence- informed decisions balance the 
benefits of a potential intervention against the 
benefits that could be achieved in other ways 
with the same resources. Economic evaluation 
studies inform these decisions and generic 
guidelines have been drawn up to guide health 
economic evaluations.1 2 Each type of evalua-
tion creates particular challenges and a litera-
ture has developed to inform decision models 
for interventions covering surgery,3–6 treat-
ments that not everyone will choose even when 
they are freely available,7 8 and service/policy 
interventions,9–15 for example. We have been 
working on health economic models to inform 
investment decisions concerning emergency 
transport systems, such as motorised ambu-
lance systems, in low/middle- income coun-
tries (LMICs). During the course of this work, 
we encountered a number of methodological 
issues, and turned to the literature for help. We 
have updated a systematic review published in 
2017,16 but found only 12 articles concerned 
with the economic evaluation of emergency 
transport in LMICs, none of which dealt with 
methodological issues (Erlannga, Lilford. 
Article in preparation. 2021). Our aim in this 
article is to describe issues in health economic 
assessment of emergency transport systems and 
discuss potential solutions.
ESTIMATING EFFECTIVENESS
Direct estimates from comparative studies
Estimates of intervention effectiveness are 
often obtained by means of studies with 
Summary box
 ► Despite the importance of the topic, there is very 
little literature available on economic evaluation of 
emergency transport in healthcare in low- income 
and middle- income countries, and none dealing with 
the methodological issues that this topic throws up.
 ► We develop a basic model for a decision maker to 
calculate cost per life saved for a particular condition 
from the correlation between survival and treatment 
delay, and the conditions affecting delay in a partic-
ular locality.
 ► We discuss how this model may be extended to deal 
with all emergencies, outcomes apart from survival 
and provision of prehospital care.
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contemporaneous controls. In policy and service delivery 
research, these studies often take the form of cluster 
studies. Ideally such studies would be randomised and 
would include baseline observations.17 However, our 
systematic review (cited above) identified no controlled 
studies of the effectiveness of emergency transport systems 
in LMICs. Moreover, even if we had found a randomised 
controlled study of the effectiveness of a transport system 
in one place, the estimate could not be used directly in a 
cost- effectiveness analysis in another place. This is for two 
reasons. First, there is a range of service specifications: 
transport for all emergencies versus specific conditions 
(eg, road traffic incidents or maternity care); transport 
types (eg, motor vehicle vs motorcycle with side- car) 
and workforce configurations (eg, with or without para-
medical support). Second, the effectiveness of a given 
emergency transport system depends on the variegated 
physical factors that affect transfer times—poor or non- 
existent roads in Liberia, dense jungles in Papua New 
Guinea, swollen rivers in Mozambique, steep slippery 
terrain in Nepal, dense traffic in Lagos and so on. In 
short, a single effectiveness measure cannot suffice across 
the range of the different service configurations and 
geographical contexts. Models are therefore required to 
estimate the effectiveness of a particular transport system 
in a particular place.
A MODELLING OF THE EFFECTIVENESS OF A PROPOSED 
TRANSPORT SYSTEM IN A PARTICULAR CONTEXT
Framing the model
The benefits of an emergency transport system are medi-
ated by reducing the time delay between injury or the 
onset of illness and treatment. The model we propose 
is thus built around the relationship between time and 
survival. We are concerned here with delay in reaching 
the facility where treatment will be given. We are not 
concerned with any delay in receiving care once an 
appropriate facility has been reached (sometimes called 
the ‘third delay’) because this is not amenable to a trans-
port system. However, we cannot ignore the question of 
whether, or when, a decision to seek care is made (the 
‘first delay’). This is because an emergency transport 
system may influence whether care is sought at all—a 
kind of supply- induced demand.18 We will therefore ‘start 
the clock’ at the point where a patient or carer recognises 
an emergency health need. We will describe the delay 
between this point and arrival at the facility by the short-
hand ‘transfer delay’ to signify the component delay that 
can be reduced by a transport system. We illustrate the 
model outputs with a theoretical population of 100 000 
over a 1- year period. We propose a basic model in the first 
instance dealing with survival only and assuming no treat-
ment ‘en route’, leaving permanent disability and para-
medical services to future developments of the model. 
We will motivate our model through the lens of a single- 
presenting condition—postpartum haemorrhage—as 
an example of an archetypal time- critical condition. We 
address the problem of consolidating costs and effects 
across all emergency conditions for later discussion.
The basic model
We need to calculate the death rate for this population 
over 1 year, absent a formal transport system. Then, we will 
calculate the mortality given a transport system assuming, 
in the first instance, that it has sufficient coverage to 
transport all who need the service. Lives saved are based 
on subtracting the latter from the former.
In figure 1, curve A represents the probability, S(t), of 
survival as a function of transfer delay, t, where t=0 is the 
moment a care need is recognised. Curve A becomes 
‘flat’ after a time in recognition of the fact that in most 
conditions some will survive even if they never reach 
an appropriate facility. The origin of curve A starts at 
a figure lower than 100% on the y axis in many (most) 
circumstances where some deaths are inevitable. Curve B 
is proportional to the probability distribution, f(t), of the 
time taken from recognising a care need to arriving at a 
care facility (transfer delay) and is intended to represent 
a plausible scenario in some part of the world. Curve C is 
the counterfactual probability distribution, f*(t), under a 
proposed new transport system.
In online supplemental appendix 1, we develop a math-
ematical model to calculate the survival gain (per 100 000 
of population), contingent on reducing the distribution 
of transfer delays from curve B to curve C.
Modelling transfer delay
However, transfer times at baseline and the extent to 
which a transport service may reduce these times, will 
vary widely by region and country. These time estimates 
depend on local geographical variables, particularly 
population density and travel times. For example, popu-
lation density is greatest in cities where people gain less 
in terms of transfer times than in more remote locations. 
Moreover, the propensity to seek care might be affected 
by location. Rather than specifying arbitrary probability 
distributions, such as curves B and C in figure 1, it would 
be more accurate to average over the non- uniform distri-
bution of population density and transfer times across the 
area of interest, in calculating expected gains in survival.
In online supplemental appendix 2, we develop a math-
ematical model to calculate a distribution of transfer 
delays from population densities, distances and ‘transfer 
delays’ by location.
Populating the basic model: parameters needed to calculate 
effectiveness
The relationship between delay and survival
A number of empirical studies concerned with the effect 
of delay on survival have used distance from facility as 
a proxy for delay. This method is flawed because such 
studies are subject to ‘survival’ bias: bias resulting from 
factors that prevent a person from being included in the 
denominator.19 The extent of the bias might be sufficient 
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such that those living further away have a lower observed 
rate of death than those living nearby—a phenomenon 
that has been observed in both high- income20 and low- 
income21 settings. Distance as a proxy for survival cannot 
be recommended for use in decision models.
Studies that focus on the relationship between time and 
outcome are not without problems either. The literature 
is limited. In LMICs, we have found the largest literature 
on delay survival relationships in the context of snake 
bite,22–27 followed by obstetrics.28 There is a limited liter-
ature from high- income countries covering trauma29–32 
and stroke.33 The literature relating to paediatric emer-
gencies and ‘the acute abdomen’ is sparse. Moreover, as 
stated, it is important to be aware that introduction of a 
new emergency transport system may be associated with 
people accessing a service who previously would not have 
done so, creating a kind of ‘survivor bias’. This bias is 
unlikely to apply to major trauma or interfacility transfer, 
where there is likely complete enumeration of cases, but 
could be a significant bias in conditions such as acute 
childhood illness, where carers do not seek treatment in 
a substantial and variable proportion of cases.34
Where the parameter estimates are not available, very 
sparse or potentially biased, then expert opinion should 
be used35 in the form of probability densities.36 The 
methods to elicit these ‘Bayesian’ probability densities 
have been described elsewhere.37–40 Probabilistic sensi-
tivity analyses can then be used to consolidate the many 
uncertainties mentioned above.41 By producing a range 
of estimates on the effect of reducing delay as a proxy for 
survival, local decision- makers can adjust the model to 
their context.
Transfer delays
As stated above, two types of data are needed to calcu-
late aggregate transfer delays under an existing and a 
proposed emergency transfer specification: local popula-
tion densities and transfer times from different locations 
in an area. Evidence is available on population densities, 
since gridded (point) estimates of population density are 
available for the whole planet up to a resolution of 1 km2, 
for example, from WorldPop.42 Estimating transfer times 
is more difficult. Travel times round the globe by the 
fastest mode of possible transport under normal (non- 
emergency) conditions, can be obtained from publicly 
available data.43 However, these data do not represent 
transfer delays under either baseline or counterfactual 
circumstances. This is because transfer delays are affected 
Figure 1 Postpartum haemorrhage. Curve A is the survival curve by time from recognition of the care need to arrival at the 
facility that will provide care, curve B represents the counterfactual time distribution from recognition of the need for facility 
care to arrival at the facility (transfer delay) under baseline conditions and curve C is the transfer delay under a proposed 
transport system. In order to construct curves B and C, it is necessary only to specify the shape of the distribution (assumed to 
be normal above), the mean transfer delays (currently and after introduction of the service) and the SD (assumed above to be 
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by delays in mobilising vehicles, need for round trips, 
different speeds allowed in emergency vehicles, loading 
patients into vehicles and so on. And transfer delay also 
has to take induced supply demand into account. There 
is thus a great need for empirical investigation and devel-
opment of exemplar models (discussed further later and 
in online supplemental appendix 2).
Incidence estimates
The rates per year for various emergency conditions (R 
in equations (3) and (4), online supplemental appendix 
1) are published for populations of 100 000 by the 
Global Burden of Disease studies.44 Modellers and users 
of models need to be wary of pitfalls in this step. First, 
definitions of conditions are applied very differently in 
different places. Second, and arguably more problem-
atic, is that the definition may not fit the kind of person 
who is transferred. For example, the definition of post-
partum haemorrhage would not necessarily correspond 
to the type of patient referred to hospital. In that case, 
the referral rates to which survival data apply may include 
people at higher or lower risk of survival than those to 
whom the survival data apply.
COST ESTIMATES
Direct costs
While production costs for vehicles and the costs of staff 
to operate them may be reasonably stable, the costs the 
service must pay are influenced by a range of issues.45 For 
example, the price of an ambulance service is subject to 
local negotiation. The period over which fixed costs are 
amortised is also a local matter. Different terrain places 
different levels of wear and tear on vehicles. Peaks and 
troughs in demand must be considered, since the trans-
port system must either tolerate clashes when not all needs 
can be served (thereby reducing the effectiveness of the 
system) or it must create redundancy (thereby driving 
up costs). These costs depend on the type of service 
contract negotiated. The notion that a given configura-
tion of transport vehicles is or is not cost- effective is thus 
not tenable; just as benefits vary by context as described 
above, so do costs. The resources required can be 
described in published literature, as recommended in a 
recent guideline,46 while local decision- makers are well- 
placed position to translate these into costs that reflect 
local contexts.
System knock-on effects
In order to estimate net costs, it is necessary to include 
an estimate of the extent to which hospital costs may be 
affected by a change in the number of people reaching 
hospital when a service is provided versus when it is 
not—supply- induced demand. Like other community 
interventions, an emergency transport service may move 
bottlenecks ‘upstream’. In the single study we located 
on this topic, a voucher scheme for round- trip transport 
to a hospital for obstetric care in Uganda resulted in a 
threefold increase in referral compared with a control 
district.47 More studies of this type are required, as we 
discuss later, but examination of verbal autopsy reports, 
such as the Million Deaths Study in India,34 can provide 
an indication of ‘pent- up’ demand.
FRAMING THE DECISION PROBLEM
Here we discuss two broader issues relating to the deci-
sion problem: the type of service (comprehensive or 
condition specific) and the issue of the broader system in 
which a transport system operates.
Specific versus comprehensive services
Ambulance services may provide open access across all 
emergency (time critical) conditions. Alternatively, an 
ambulance service may be hypothecated to a particular 
‘client group’: road traffic incident victims or obstetric 
services, for example.48 49 Low- income countries may 
implement condition- specific (hypothecated) services 
with a view to upgrading to comprehensive services as 
their economies develop. It is easier to compute the bene-
fits and costs of an ambulance service over a specific client 
group than for a service designed to cater for all emer-
gencies. When the service is comprehensive, covering all 
emergencies, then the costs and effects must be averaged 
over all the conditions for which it is deployed, weighted 
by patient volumes. This is an enormous and potentially 
open- ended task. An approach to this sort of problem is 
to select an ‘inframarginal’ set of presenting conditions 
where we expect the greatest value from provision of a 
service. In the context of emergency transport, the infra-
marginal group may be restricted to major categories of 
emergency condition, such as major trauma, obstetric 
emergency, life- threatening infection in a child and ‘the 
acute abdomen’. The cost- effectiveness of the service 
is then aggregated to a population level. If the positive 
effect among the inframarginal group is sufficient when 
covering the fixed cost of the service, the marginal costs 
and benefits of adding other presenting conditions when 
spare capacity exists can be considered. That said, the 
issue of supply- induced demand described above must 
also be considered, and this issue is likely to be greater 
in a system catering for all perceived emergencies than a 
system targeted at a specific clinical groups, such as child-
birth or road traffic incidents.
Emergency transport services in a broader systems context
We have argued that emergency transport systems have 
knock- on effects on hospitals. In post- conflict situations, 
where there are no hospitals worthy of the name, it 
makes no sense to fund an emergency transport system. 
As the secondary care system of hospitals develops, so the 
value of transport systems will increase. There must be 
a theoretical optimal development pathway that could 
be defined in health economic (or indeed in broader 
economic) terms. Such a system- wide approach to service 
development is advocated by the WHO Choices Guide-
lines.50 Such an approach, while perhaps optimal, does 
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transfer time would be an essential part of a model 
that sought to optimise value for money by developing 
services iteratively to follow an optimised pathway. We 
also note, that optimal as such a system- wide model might 
be, decision- makers are often, or usually, presented with 
more specific investment opportunities.
DISCUSSION
Modelling outcomes of emergency transport decisions
The systematic review we quote above shows that there 
is little or no methodological literature in the field of 
economic evaluation of emergency transport. In addi-
tion, we do not find any comparative studies of the 
effectiveness of emergency transport systems in LMICs. 
Even if such studies existed, it would still be necessary to 
extrapolate beyond the observed effects, given the wide 
variety of system specifications and contexts in which 
they might be used. Modelling will therefore always be 
required in the field of emergency transport economics, 
although, as we discuss below, better data are needed to 
populate models. A crucial insight from this study is that 
the effects of an emergency transport system, and there-
fore the benefits that might derive, turn on reducing 
the delay to treatment (including infinite delay for the 
proportion of people who otherwise would not seek care 
at all). Thus, ‘reduced delay’ can be thought of as a type 
of proxy for the intervention; first estimate the effect a 
proposed intervention will have on delay and then use 
that estimate to calculate the contingent survival effect 
over the population of interest (equation (9), online 
supplemental appendix 2 refers).
The role of the decision-maker in framing and populating the 
model
The high- context dependency of factors, such as reduc-
tions in transport time, means that some of the param-
eters or distributions required as inputs for the models 
simply cannot be taken from the literature and applied 
without modification to a new situation. This means that 
local decision- makers are not just asked to use judgement 
in interpreting the model, but must actually contribute to 
parameter estimates with which to populate the model. 
Table 1 Some urgent research needs to inform models
Estimating health benefit
Delay and outcome More and better data on delay outcome correlations are needed but these have proven hard to come 
by, save for certain specific diseases such as thrombotic stroke.
Disability/quality of 
life effects of delay
The literature on delay and outcome focuses on death with some notable exceptions, such as stroke, 
in high- income countries.52 Yet, the effects of delay may involve many outcomes, including many types 
of permanent and short- term physical and mental effects. Work is needed on prognosis for survivors to 
inform cohort or simulation models of future mortality, quality of life and costs.
Paramedical services Delay in getting to hospital and delay in the start of treatment differ according to the availability of 
people and facilities en route and how they are used. This topic has been studied in high- income 
countries, but remains a contentious issue in the medical literature.53 54
Reducing delay by means of transport systems
Current transfer times Data are needed over a range of ‘specimen’ geographical and service configuration scenarios to 
describe how people somehow manage to reach hospital even when there is no formal transport 
system in place.
Effect on transport 
services on transfer 
times
Real- time studies of implementations of improved transport services are required across service 
specification and contextual variables. We need to better estimate how services change proportions 
who set out for a facility, the time taken to reach a decision to try to reach a facility and transfer times.
Transfer routes The above studies should document changes in pathways to care, since delay may result when a 
patient is taken to an inappropriate venue.
Exemplars Building on the above, we need worked models of changes in call- out to arrival times over a range of 
different types of geographical area.
Data relating to costs
Implementation costs More and better information is needed on the cost of ambulance services by types and number of 
vehicles, human resources and type of procurement contract. We have found that policy leads are 
reluctant to divulge this information which is often locally negotiated.
Operational effects It would be useful to collect data on the costs of maintaining different types of vehicle in the field and 
how these costs are affected by the type of contract.
Logistics The size of vehicle fleet needed to cope with peaks and troughs and delays when repairs and spare 
parts are acquired should be explored using Queue theory.
Paramedical services Costs of paramedical services to offset against benefits above, by reason for call- out.
Knock- on effects The effects of transport services on demand (both intended and unintended) are tractable and should 
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The corollary is that, where possible, decision- makers 
and modellers should work together. However, health 
economists are a scarce resource, and models are often 
published in the literature with the intention that they 
will inform practice. Given a range of published models 
over a wide range of scenario types, a decision- maker in a 
particular place could select and adapt the scenario most 
similar to the local context.
Interim solutions
Pending further research, ‘back- of- the- envelope calcula-
tions’ or simple models to shed some light on a decision 
may help. For example, the cost- effectiveness equation 
model can be rearranged in such a way as to find out 
whether a local intervention of known cost is likely to fall 
below the cost- effectiveness threshold for the country 
concerned. Thus, given an appropriate threshold51 and a 
net cost, the model could define how effective the inter-
vention would have to be in order to be cost- effective in 
a given economy.
Research gaps
A non- exhaustive list of research imperatives is given in 
table 1.
CONCLUSION
We present some issues that should be considered by 
anyone attempting cost- effectiveness modelling of trans-
port systems in LMICs. There is a shortfall in health 
economic studies of emergency transport systems in 
healthcare, and we are not aware of any methodolog-
ical literature on this subject. Our model is basic but can 
be extended to include outcomes apart from survival, 
prehospital care and other considerations. We offer our 
analysis as an early contribution to an important, under- 
researched and hopefully burgeoning field of enquiry.
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